Treating EGFR Mutant NSCLC in Brazil

Episode
163
Soundcloud
Share

This episode of Lung Cancer Considered examines the treatment of EGFR-positive lung cancer in Brazil from early-stage disease to metastatic lung cancer.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Victor Marcondes
Victor Marcondes

MD

Thoracic Medical Oncologist
Oncomed Oncologia
Juliana Ominelli
Juliana Ominelli

MD

Medical Oncologist
Brazilian National Cancer Institute – Oncologia DASA